Blood disorders in patients with GI angiodysplasia
Part of Digestive system clinical trials.
This trial looks at blood changes in people who have been diagnosed with angiodysplasia (abnormal blood vessels in the gut) that caused bleeding. By studying these patients, researchers hope to better understand the link between angiodyplasia and blood disorders.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have had gastrointestinal bleeding that was found to be caused by angiodyplasia (abnormal blood vessels in the gut) during an upper endoscopy or colonoscopy
- You are not bleeding from another cause
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies blood disorders in people with angiodysplasia, which are abnormal blood vessels in the digestive tract that can cause bleeding. It aims to understand how these blood vessel problems affect your blood health.
This trial is looking at patients with ischemic heart disease who are taking one or two antiplatelet drugs (like aspirin or clopidogrel) and have had gastrointestinal bleeding. The goal is to study this problem and find better ways to manage it.
This trial uses an endoscopy camera to look at the inside of your upper digestive tract to find the cause of bleeding. It may help doctors understand what is happening and decide on the best treatment.
This trial tests whether giving blood more freely (liberal) or more sparingly (restrictive) is better for patients with upper gastrointestinal bleeding who are anemic. It aims to find the safest approach for you.
This trial is looking at adults who have bleeding in the upper part of the stomach or gut that was caused by a medication. The goal is to learn more about how this type of bleeding happens and how to treat it.
This study looks at blood stem cells in children with inflammatory bowel disease (IBD) or rectal bleeding, compared with healthy children. It aims to understand why the immune system attacks the gut, which could lead to new treatments.
Hear when a new GI Bleeding trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.